REBECCA JOHNSON: Open Payments
NPI 1083864045 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,054 in 149 payments from 30 companies in 2025. Trend: 2023 $2,323 · 2024 $2,476 · 2025 $3,054
Food & beverage: $2,916Education: $138
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $477 |
| Teva Pharmaceuticals USA, Inc. | 15 | $400 |
| Novo Nordisk Inc | 16 | $290 |
| AstraZeneca Pharmaceuticals LP | 7 | $197 |
| Amgen Inc. | 10 | $182 |
| PFIZER INC. | 12 | $163 |
| Lundbeck LLC | 8 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $137 |
| Novartis Pharmaceuticals Corporation | 5 | $131 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $92 |
Products named: AUSTEDO XR, REXULTI, QULIPTA, AIRSUPRA, UBRELVY, LEQVIO, JARDIANCE, Ozempic.
Industry payments across WA — which companies pay providers there.
